SAFETYLIT WEEKLY UPDATE

We compile citations and summaries of about 400 new articles every week.
RSS Feed

HELP: Tutorials | FAQ
CONTACT US: Contact info

Search Results

Journal Article

Citation

Keating GM, Sanford M. Drug. Ther. Persp. 2012; 28(3): 7-11.

Copyright

(Copyright © 2012)

DOI

10.2165/11209210-000000000-00000

PMID

unavailable

Abstract

Once-daily oral quetiapine extended release (XR) is effective as an adjunct to antidepressant therapy in the treatment of patients with a major depressive episode and an inadequate response to an antidepressant alone. The tolerability profile of quetiapine XR when administered as adjunctive therapy in patients with major depressive disorder is consistent with that seen in other indications. © 2012 Adis Data Information BV. All rights reserved.


Language: en

Keywords

human; insomnia; suicidal ideation; suicide attempt; major depression; review; fatigue; sexual dysfunction; sedation; xerostomia; unclassified drug; headache; quetiapine; somnolence; constipation; drug mechanism; extrapyramidal symptom; drug tolerability; nausea; weight gain; side effect; drug indication; Quetiapine; dizziness; drug dose increase; sustained release formulation; Adis-Clinical-Q-and-A; Major-depressive-disorder; seroquel depot; seroquel prolong; seroquel sr; seroquel xl

NEW SEARCH


All SafetyLit records are available for automatic download to Zotero & Mendeley
Print